GENE ONLINE|News &
Opinion
Blog

2021-12-03| ChinaIPO

BeiGene launches IPO on Shanghai’s STAR market to raise $3B

by Sahana Shankar
Share To
BeiGene Ltd announces the third round of its initial public offering (IPO) on the STAR market of Shanghai Stock Exchange to raise US $3.5 billion. The global biotech company, based in Beijing, China offers around 115 million ordinary shares, representing 8.62% of its total outstanding shares. 

GO Prime with only $1.49 now

SUBSCRIBE NOW
LATEST
Biotech Showcase 2022: Healing the Psyche with Psychedelia
2022-01-17
GO PRIME
Sex Dimorphism in Obesity and the Impact of Estrogen Hormone Therapy on Cardiometabolic Health
2022-01-17
GO PRIME
ARM 2022: Industry Briefs on Cell and Gene Therapies
2022-01-17
GO PRIME
Study Reveals a Form of Four-Stranded DNA that Links Protein Deficiency and Premature Aging
2022-01-17
Shanghai’s Everest Medicines Licenses Covid-19 Oral Antivirals from Singapore’s National Drug Discovery Platform
2022-01-17
Digital Health Programme to Connect British and Taiwanese Leaders
2022-01-17
Pfizer: Pneumonia Shot Can Be Given with COVID-19 Vaccine in Older Adults
2022-01-16
READ MORE
EVENT
2022-01-10
Biotech Showcase™ 2022
Online
2022-02-10
Medtech Connect Osaka 2022：The challenges to realising next generation therapeutics
Online
2022-02-10
The 2022 UK-Taiwan Digital Health Programme: Webinar
Virtual
2022-02-14
BIO CEO & Investor Conference
Online and on-site
2022-03-07
The 2022 UK-Taiwan Digital Health Programme: B2B Matchmaking
Virtual
2022-03-09
The Festival of Biologics
Marriott Marquis San Diego
SEE MORE
Newsletter
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2022 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top

Enjoy Your First 14 Days for $1.49

SUBSCRIBE NOW

Create an account with us now to say goodbye to all the pop-ups!